The Miami Entrepreneur

: Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter

Read Time:6 Second

The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations. 

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Market Extra: The housing market chill is biting into Fed’s mortgage bond exit
Next post Earnings Results: Harley-Davidson’s stock on track for highest close in almost two years after earnings crush estimates